Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(In thousands, except share amounts)
  September 30,
2021
December 31,
2020
ASSETS (Unaudited)  
Current assets:    
Cash and cash equivalents $ 87,671 $ 105,035
Receivables from service providers 16,082 4,711
Short-term investments 13,342 25,019
Restricted cash 8,817 8,519
Fiduciary funds - restricted 1,507 4,106
Trade accounts receivable, less allowances of $19,489 and $22,691, respectively 146,623 142,847
Other current assets 81,429 71,661
Total current assets 355,471 361,898
     
Property and equipment, net 54,076 52,521
Right-of-use assets 10,984 12,372
Goodwill 940,600 949,037
Intangibles, net 49,312 50,880
Indefinite-lived intangibles 16,647 21,647
Capitalized software development costs, net 21,272 19,389
Deferred tax asset, net 66,508 63,402
Other assets 34,962 38,707
Total assets $ 1,549,832 $ 1,569,853
     
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Current liabilities:    
Accounts payable and accrued liabilities $ 62,265 $ 64,764
Payables to service agents 7,921 5,281
Accrued payroll and related benefits 8,607 11,792
Working capital facility 7,991 16,643
Fiduciary funds - restricted 1,507 4,106
Short-term debt 674 894
Current portion of long term debt and financing lease obligations, net of deferred financing costs of $1,635 and $920, respectively 26,701 23,621
Contract liabilities 32,261 32,898
Lease liability 3,172 3,905
Other current liabilities 28,909 27,486
Total current liabilities 180,008 191,390
     
Revolving line of credit 439,402 439,402
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $671 and $1,062, respectively 191,788 232,140
Contingent liability for accrued earn-out acquisition consideration 2,563
Contract liabilities 8,141 8,033
Lease liability 8,011 8,540
Deferred tax liability, net 1,358 1,235
Other liabilities 26,857 29,009
Total liabilities 858,128 909,749
     
     
Stockholders’ equity:    
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2021 and December 31, 2020
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2021 and December 31, 2020
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,684,387 issued and outstanding, at September 30, 2021, and 30,515,334 issued and outstanding at December 31, 2020 3,068 3,052
Additional paid-in capital 14,994 11,126
Retained earnings 746,104 700,304
Accumulated other comprehensive loss (118,083 (101,503
Total Ebix, Inc. stockholders’ equity 646,083 612,979
Noncontrolling interest 45,621 47,125
Total stockholders’ equity 691,704 660,104
Total liabilities and stockholders’ equity $ 1,549,832 $ 1,569,853

Investor Contacts

EBIX Inc
1 Ebix Way, Johns Creek, Georgia 30097
Ph: 678-281-2027 Fax: 678-281-2019

IR@ebix.com

David Collins, Tanya Kamatu, Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com